Q&A: MD Anderson's Dean Tang Talks miR-34a and Its Role in Prostate Cancer

Tang and colleagues from Mirna Therapeutics reported that the microRNA miR-34a inhibits prostate cancer stem cells, as well as metastasis, in tumor-bearing animal models of the disease.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories